Patients with the rs118192176 GG genotype may have a decreased, but not absent, risk for malignant hyperthermia based on this variant when treated with volatile anesthetics (desflurane, enflurane, halothane, isoflurane, methoxyflurane, sevoflurane) and/or succinylcholine as compared to patients with the AA or AG genotype. Other genetic or clinical factors may also influence the risk for malignant hyperthermia.